Bradley Hardiman

Bradley Hardiman is a senior executive in the pharmaceutical industry, currently serving as the Senior Director of Ventures - Business Development at Astellas Pharma Europe.23 In this role, he leads efforts to identify and evaluate opportunities for innovation and strategic partnerships.13

Key Responsibilities

Hardiman's primary focus areas include:

• Scouting and evaluating partnership opportunities for Astellas Europe1
• Unlocking early innovation through strategic initiatives3
• Leading venture management activities for Astellas4

Professional Background

Hardiman is based in Cambridge, UK2, and has established himself as a key figure in the biopharmaceutical industry. His expertise spans:

• Business development in the pharmaceutical sector
• Venture management and investment in biotech startups
• Evaluation of emerging technologies and potential partnerships

Industry Involvement

Hardiman is actively involved in the biotech and pharmaceutical community:

• He participates in industry events such as BIO-Europe Spring, sharing insights on market trends and innovation3
• He has been featured in discussions about biopharma dealmaking and the evolving landscape of the industry4
• Hardiman is a speaker at conferences like the LSX World Congress, where he contributes to sessions on finding and funding innovation5

Bradley Hardiman's role at Astellas Pharma Europe positions him at the forefront of pharmaceutical innovation and strategic partnerships, making him a notable figure in the industry's efforts to advance healthcare through collaboration and investment in emerging technologies.